Related Experiment Video
Updated: May 30, 2026

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
Published on: May 12, 2019
Changing depot medroxyprogesterone acetate access at a faith-based institution
Maryam Guiahi1, Moira McNulty, Gretchen Garbe
1Division of Family Planning, Department of Obstetrics and Gynecology, Columbia University, New York, NY 10032, USA. mg2852@columbia.edu
Immediate postpartum depot medroxyprogesterone acetate (DMPA) significantly reduced repeat pregnancies in young women. Limiting access to DMPA for noncontraceptive uses increased pregnancy rates in this demographic.
Area of Science:
- Reproductive Health
- Public Health
- Clinical Obstetrics
Background:
- Loyola University Medical Center, a faith-based institution, previously provided depot medroxyprogesterone acetate (DMPA) for noncontraceptive postpartum uses.
- This study examines the impact of discontinuing this practice.
Purpose of the Study:
- To evaluate the association between immediate postpartum depot medroxyprogesterone acetate (DMPA) and repeat pregnancy rates.
- To analyze factors influencing repeat pregnancy in young women.
Main Methods:
- A historical cohort study compared young women (≤25 years) who received immediate postpartum DMPA with those who did not.
- Logistic regression analysis was employed to assess associations between patient characteristics and repeat pregnancy within one year.
Main Results:
- The study included 258 women, with 105 (40.70%) exposed to DMPA.
- Multivariable analysis, adjusting for race and religion, revealed a statistically significant decrease in repeat pregnancy among patients receiving immediate postpartum DMPA (OR 0.27, 95% CI 0.10-0.72).
Conclusions:
- Restricting access to DMPA for noncontraceptive indications postpartum led to increased pregnancy rates.
- This highlights the importance of continued access to contraception for young women.
Related Concept Videos
Intrauterine Drug Delivery Systems
Birth Control Methods
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
